Metabolite Profiles of Diabetes Incidence and Intervention Response in the Diabetes Prevention Program
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Identifying novel biomarkers of type 2 diabetes risk may improve prediction and prevention among individuals at high risk of the disease and elucidate new biological pathways relevant to diabetes development. We performed plasma metabolite profiling in the Diabetes Prevention Program (DPP), a completed trial that randomized high-risk individuals to lifestyle, metformin, or placebo interventions. Previously reported markers, branched-chain and aromatic amino acids and glutamine/glutamate, were associated with incident diabetes (P < 0.05 for all), but these associations were attenuated upon adjustment for clinical and biochemical measures. By contrast, baseline levels of betaine, also known as glycine betaine (hazard ratio 0.84 per SD log metabolite level, P = 0.02), and three other metabolites were associated with incident diabetes even after adjustment. Moreover, betaine was increased by the lifestyle intervention, which was the most effective approach to preventing diabetes, and increases in betaine at 2 years were also associated with lower diabetes incidence (P = 0.01). Our findings indicate betaine is a marker of diabetes risk among high-risk individuals both at baseline and during preventive interventions and they complement animal models demonstrating a direct role for betaine in modulating metabolic health.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk
Tang, W. H. W., Wang, Z., Levison, B. S., Koeth, R. A., Britt, E. B., Fu, X., Wu, Y., & Hazen, S. L. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1109400 · Cited by 3,400
Metabolite profiles and the risk of developing diabetes
Wang, T. J., Larson, M. G., Vasan, R. S., Cheng, S., Rhee, E. P., McCabe, E., Lewis, G. D., Fox, C. S., Jacques, P. F., Fernandez, C., et al. (2011) · Nature Medicine · doi:10.1038/nm.2307 · Cited by 3,143 · cited 18×
“We have previously demonstrated that median coefficient of variances are #20% for 74% of metabolites and #10% for 54% of metabolites, including BCAA/As (2).”
InfluentialSelf-citation(1999) · Diabetes Care · doi:10.2337/diacare.22.4.623 · Cited by 725
Tang, W. H. W., Wang, Z., Fan, Y., Levison, B., Hazen, J. E., Donahue, L. M., Wu, Y., & Hazen, S. L. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.02.617 · Cited by 681
Rhee, E. P., Cheng, S., Larson, M. G., Walford, G. A., Lewis, G. D., McCabe, E., Yang, E., Farrell, L., Fox, C. S., O’Donnell, C. J., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44442 · Cited by 647 · cited 2×
“Metabolite profiling was performed as previously described (2,7,8).”
Self-citationMetabolomics and Cardiovascular Biomarker Discovery
Rhee, E. P., & Gerszten, R. E. (2012) · Clinical Chemistry · doi:10.1373/clinchem.2011.169573 · Cited by 232 · cited 1×
“Our results are thus agnostic to the predictive capacity of metabolites not measured on our platform (26,27).”
Self-citationMueller, D. M., Allenspach, M., Othman, A., Saely, C. H., Muendlein, A., Vonbank, A., Drexel, H., & von Eckardstein, A. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.10.091 · Cited by 217
Xie, W., Wood, A. R., Lyssenko, V., Weedon, M. N., Knowles, J. W., Alkayyali, S., Assimes, T. L., Quertermous, T., Abbasi, F., Paananen, J., et al. (2013) · Diabetes · doi:10.2337/db12-0876 · Cited by 83
Cited by
Glycine Metabolism and Its Alterations in Obesity and Metabolic Diseases
Alves, A., Bassot, A., Bulteau, A.-L., Pirola, L., & Morio, B. (2019) · Nutrients · doi:10.3390/nu11061356 · Cited by 365
Vanweert, F., Schrauwen, P., & Phielix, E. (2022) · Nutrition & Diabetes · doi:10.1038/s41387-022-00213-3 · Cited by 289
Precision nutrition for prevention and management of type 2 diabetes
Wang, D. D., & Hu, F. B. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30037-8 · Cited by 267
Gene-Diet Interaction and Precision Nutrition in Obesity
Heianza, Y., & Qi, L. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18040787 · Cited by 204
A roadmap to achieve pharmacological precision medicine in diabetes
Florez, J. C., & Pearson, E. R. (2022) · Diabetologia · doi:10.1007/s00125-022-05732-3 · Cited by 30
Self-citationRoles of Amino Acid Derivatives in the Regulation of Obesity
Zheng, J., Xiao, H., Duan, Y., Song, B., Zheng, C., Guo, Q., Li, F., & Li, T. (2021) · Food & Function · doi:10.1039/d1fo00780g · Cited by 20
Gadgil, M. D., Kanaya, A. M., Sands, C., Chekmeneva, E., Lewis, M. R., Kandula, N. R., & Herrington, D. M. (2022) · The Journal of Nutrition · doi:10.1093/jn/nxac191 · Cited by 16
Metadata
- Authors
- Walford, G. A., Ma, Y., Clish, C., Florez, J. C., Wang, T. J., Gerszten, R. E., & for the Diabetes Prevention Program Research Group
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2016-02-09
- Volume
- 65
- Issue
- 5
- Pages
- 1424-1433
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2305603989
- Cited by
- 125
- References
- 10
- FWCI
- 6.77
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.